🏥 Health
1d ago
Novel Drug Impresses in Metastatic Pancreatic Cancer
Source ↗
👁 0
💬 0
(MedPage Today) -- SAN DIEGO -- Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable safety profile and demonstrated promising efficacy both in combination with chemotherapy and as monotherapy...
Comments (0)